Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-05-10
2011-05-10
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S599000, C544S061000, C544S175000, C544S373000, C546S113000, C546S121000, C546S176000, C546S245000, C546S277400, C546S314000, C548S204000, C548S236000, C548S255000, C548S341500, C548S362500, C548S376100, C548S503000, C548S530000, C548S564000, C548S950000, C549S058000, C549S059000, C549S356000, C549S505000
Reexamination Certificate
active
07939531
ABSTRACT:
The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I,wherein the variables Q and R are defined as described herein, which inhibit JAK and SYK and are useful for the treatment of auto-immune and inflammatory diseases.
REFERENCES:
patent: 2006/0148801 (2006-07-01), Hsieh et al.
patent: 2007/0049615 (2007-03-01), Ibrahim et al.
patent: 0147922 (2001-07-01), None
patent: 03000688 (2003-01-01), None
patent: 03082868 (2003-10-01), None
patent: 2008033798 (2008-03-01), None
patent: 2008063888 (2008-05-01), None
patent: 2008079903 (2008-07-01), None
Bamberg Joe Timothy
Bartlett Mark
DuBois Daisy Joe
Elworthy Todd Richard
Hendricks Robert Than
Johnston George W.
Kisko Jennifer L.
Roche Palo Alto
Tramaloni Dennis P.
Willis Douglas M
LandOfFree
Pyrrolopyrazine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolopyrazine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolopyrazine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2655223